Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing deferasirox (medicinal product) | est un(e) (attribut) | Product containing chelating agent (product) | true | Inferred relationship | Some | ||
| Product containing deferasirox (medicinal product) | est un(e) (attribut) | Product containing heavy metal antagonist (product) | false | Inferred relationship | Some | ||
| Product containing deferasirox (medicinal product) | a pour principe actif (attribut) | Deferasirox (substance) | true | Inferred relationship | Some | 1 | |
| Product containing deferasirox (medicinal product) | est un(e) (attribut) | Product containing azole (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Deferasirox only product | est un(e) (attribut) | True | Product containing deferasirox (medicinal product) | Inferred relationship | Some | |
| Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) | est un(e) (attribut) | False | Product containing deferasirox (medicinal product) | Inferred relationship | Some | |
| Deferasirox 250 mg tablet for oral suspension | est un(e) (attribut) | False | Product containing deferasirox (medicinal product) | Inferred relationship | Some | |
| Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) | est un(e) (attribut) | False | Product containing deferasirox (medicinal product) | Inferred relationship | Some | |
| Product containing deferasirox in oral dose form (medicinal product form) | est un(e) (attribut) | True | Product containing deferasirox (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets